Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03154619
Recruitment Status : Recruiting
First Posted : May 16, 2017
Last Update Posted : April 4, 2019
TR Therapeutics, Inc.
Information provided by (Responsible Party):
SerenaGroup, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : November 2019